Huationg Global Limited (SGX:41B)

Ligand Pharmaceuticals Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	110.66	70.69	23.07	10.35	32.9
Short-Term Investments	0.77	0.8	0.81	0.83	0.78
Cash & Short-Term Investments	111.43	71.49	23.87	11.18	33.68
Cash Growth	55.86%	199.50%	113.61%	-66.82%	519.55%
Accounts Receivable	89.51	107.04	94.97	105.86	116.86
Other Receivables	2.28	1.67	1.81	0.55	0.62
Receivables	91.79	108.71	96.78	106.4	117.48
Inventory	3.22	2.24	1.57	1.4	1.27
Prepaid Expenses	8.98	4.34	2.18	2.68	4.57
Other Current Assets	4.94	2.16	25.66	3.78	1.1
Total Current Assets	220.36	188.95	150.06	125.44	158.09
Property, Plant & Equipment	116.59	87.13	64.36	96.52	107.79
Long-Term Investments	-	-	0.27	1.72	0.71
Other Intangible Assets	0.1	0.05	0.06	0.08	0.1
Other Long-Term Assets	3.29	5.95	2.83	2.95	5.39
Total Assets	340.34	282.07	217.58	226.71	272.07
Accounts Payable	40.37	41.46	24.55	26.48	45.17
Accrued Expenses	7.26	6.59	6.16	4.89	4.18
Short-Term Debt	46.77	30.67	30.74	35.27	59.42
Current Portion of Long-Term Debt	-	-	4.35	8.12	4.21
Current Portion of Leases	9.78	9.6	11.35	15.16	15.68
Current Income Taxes Payable	3.75	3.53	2.85	0.67	-
Current Unearned Revenue	72.4	41.81	2.7	4.67	12.37
Other Current Liabilities	12.99	21.76	16.1	6.88	9.44
Total Current Liabilities	193.31	155.41	98.79	102.15	150.47
Long-Term Debt	9.67	8.64	12.57	14.26	15.62
Long-Term Leases	22.2	18.44	13.27	25.83	37.81
Long-Term Unearned Revenue	-	-	-	-	0.27
Long-Term Deferred Tax Liabilities	3.55	2.82	1.86	3.56	3.97
Other Long-Term Liabilities	1	1	8.51	8.78	-
Total Liabilities	229.72	186.31	134.99	154.58	208.13
Common Stock	41.16	41.16	41.16	41.08	38.68
Retained Earnings	85.35	70.76	57.91	48.22	42.89
Comprehensive Income & Other	-14.78	-15.1	-15.47	-16.23	-16.83
Total Common Equity	111.72	96.82	83.6	73.07	64.74
Minority Interest	-1.1	-1.06	-1.01	-0.95	-0.81
Shareholders' Equity	110.62	95.76	82.58	72.13	63.94
Total Liabilities & Equity	340.34	282.07	217.58	226.71	272.07
Total Debt	88.42	67.35	72.27	98.64	132.74
Net Cash (Debt)	23.02	4.14	-48.4	-87.47	-99.06
Net Cash Growth	455.41%	-	-	-	-
Net Cash Per Share	0.13	0.02	-0.27	-0.57	-0.65
Filing Date Shares Outstanding	177.24	177.24	177.24	176.38	151.38
Total Common Shares Outstanding	177.24	177.24	177.24	176.38	151.38
Working Capital	27.06	33.53	51.27	23.29	7.63
Book Value Per Share	0.63	0.55	0.47	0.41	0.43
Tangible Book Value	111.63	96.77	83.53	72.99	64.65
Tangible Book Value Per Share	0.63	0.55	0.47	0.41	0.43
Buildings	0.51	0.5	0.47	0.46	0.45
Machinery	190.16	146.15	118.79	108.57	84.85

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.